Do Sacral/Peripheral Lesions Contribute to Detrusor-Sphincter Dyssynergia?

被引:2
作者
Takahashi, Osamu [2 ]
Sakakibara, Ryuji [1 ]
Tsunoyama, Kuniko [3 ]
Tateno, Fuyuki [1 ]
Yano, Masashi [4 ]
Sugiyama, Megumi [3 ]
Uchiyama, Tomoyuki [5 ]
Yamamoto, Tatsuya [5 ]
Awa, Yusuke [6 ]
Yamaguchi, Chiharu [7 ]
Yamanishi, Tomonori [8 ]
Kishi, Masahiko [1 ]
Tsuyuzaki, Yohei [1 ]
机构
[1] Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Neurol, Sakura, Ibaraki 2858741, Japan
[2] Toho Univ, Sakura Med Ctr, Clin Physiol Unit, Sakura, Ibaraki 2858741, Japan
[3] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
[4] Toho Univ, Sakura Med Ctr, Dept Urol, Sakura, Ibaraki 2858741, Japan
[5] Chiba Univ, Dept Neurol, Chiba, Japan
[6] Chiba Univ, Dept Urol, Chiba, Japan
[7] Chiba Univ Hosp, Cent Lab Unit, Chiba, Japan
[8] Dokkyo Med Coll, Dept Urol, Mibu, Tochigi, Japan
关键词
detrusor-sphincter dyssynergia; neuropathy; sacral Onuf's nucleus; LOWER URINARY-TRACT; MULTIPLE SYSTEM ATROPHY; LUMBOSACRAL SPINAL-CORD; INJURED RATS; BLADDER; ELECTROMYOGRAPHY; SUPPRESSION; MICTURITION; DISORDERS;
D O I
10.1111/j.1757-5672.2012.00148.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: While detrusor-sphincter dyssynergia (DSD) occurs in conjunction with lesions between the brainstem and the sacral cord, it is not well known whether sacral/peripheral lesions contribute to DSD. We studied the relationship between DSD and sacral/peripheral lesions. Methods: One hundred and forty-four patients with diverse neurologic etiologies underwent urodynamic study and analysis of motor unit potentials in the external sphincter muscles, 117 of whom were able to void during a urodynamic test. Sacral/peripheral lesion (SPL) is defined as neurogenic change in motor unit potentials. Detrusor overactivity (DO) is defined as involuntary detrusor contractions during the filling phase, which commonly occurs in lesions above the sacral cord. We considered DO as a putative indicator of supra-sacral lesion. Results: DSD was found in 44 (30.6%), SPL in 71 (49.3%), and DO in 83 (57.6%) of 144 patients, respectively. The incidence of DSD was the same in the SPL positive group (31%) and the SPL negative group (30.1%). By contrast, within the subgroup of patients without DO, the incidence of DSD was significantly more common in the SPL positive group (41.4%) than in the SPL negative group (25.0%) (P < 0.05). In 53 of the SPL positive group who were able to void, postvoid residual >100 mL was more common in patients with DSD (not statistically significant). Conclusion: The results of the present study suggest that not only suprasacral pathology, but also sacral/peripheral lesions can produce DSD. In light of the previous reports, DSD might also result from partial lesions in peripheral branches of the sphincter circuit.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 50 条
  • [21] Treatment of detrusor-sphincter dyssynergia by pudendal nerve block in patients with spinal cord injury
    Tsai, SJ
    Lew, HL
    Date, E
    Bih, LI
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2002, 83 (05): : 714 - 717
  • [22] Use of the Memokath® for detrusor-sphincter dyssynergia after spinal cord injury -: a cautionary tale
    Low, AI
    McRae, PJ
    SPINAL CORD, 1998, 36 (01) : 39 - 44
  • [23] Management of the Detrusor Sphincter Dyssynergia
    Pichon B.
    Bloch F.
    Bart S.
    Roze E.
    Perrigot M.
    Vidailhet M.
    Current Bladder Dysfunction Reports, 2013, 8 (2) : 114 - 122
  • [24] Botulinum A toxin as a treatment of detrusor-sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injections
    Schurch, B
    Hodler, J
    Rodic, B
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04) : 474 - 476
  • [25] Removal of UroLume endoprosthesis: Experience of the North American study group for detrusor-sphincter dyssynergia application
    Gajewski, JB
    Chancellor, MB
    Ackman, CFD
    Appell, RA
    Bennett, J
    Binard, J
    Boone, TB
    Chetner, MP
    Crewalk, JA
    Defalco, A
    Foote, J
    Green, B
    Juma, S
    Jung, SY
    Linsenmeyer, TA
    Macaluso, JN
    Macmillan, R
    Mayo, M
    Ozawa, H
    Roehrborn, CG
    Schmidt, J
    Shenot, PJ
    Stone, A
    Vazquez, A
    Killorin, W
    Rivas, DA
    JOURNAL OF UROLOGY, 2000, 163 (03) : 773 - 776
  • [26] Pediatric case of the day - Hinman syndrome (nonneurogenic neurogenic bladder [NNNB], detrusor-sphincter dyssynergia)
    Das Narla, L
    Hingsbergen, EA
    Fulcher, AS
    Harrison, LS
    RADIOGRAPHICS, 1998, 18 (01) : 258 - 260
  • [27] Urethral stents for detrusor sphincter dyssynergia
    Nambirajan, T
    Woolsey, S
    Mahendra, V
    Stone, AR
    Walsh, IK
    BJU INTERNATIONAL, 2005, 95 (03) : 350 - 353
  • [28] Functional MRI in patients with detrusor sphincter dyssynergia: Is the neural circuit affected?
    Seseke, Sandra
    Leitsmann, Conrad
    Hijazi, Sameh
    Trojan, Lutz
    Dechent, Peter
    NEUROUROLOGY AND URODYNAMICS, 2019, 38 (08) : 2104 - 2111
  • [29] Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: A prospective study in 24 spinal cord injury patients
    Schurch, B
    Hauri, D
    Rodic, B
    Curt, A
    Meyer, M
    Rossier, AB
    JOURNAL OF UROLOGY, 1996, 155 (03) : 1023 - 1029
  • [30] Oral nitric oxide donors:: A new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?
    Reitz, A
    Knapp, PA
    Müntener, M
    Schurch, B
    EUROPEAN UROLOGY, 2004, 45 (04) : 516 - 520